These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 14737845)

  • 21. Endothelial function as intermediary endpoint in hypertension: comments.
    Kiowski W
    Blood Press Suppl; 1997; 2():71-5. PubMed ID: 9495631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of treatment strategy on endothelial function.
    Tomasoni L; Sitia S; Borghi C; Cicero AF; Ceconi C; Cecaro F; Morganti A; De Gennaro Colonna V; Guazzi M; Morricone L; Malavazos AE; Marino P; Cavallino C; Shoenfeld Y; Turiel M
    Autoimmun Rev; 2010 Oct; 9(12):840-4. PubMed ID: 20678593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
    Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
    Agabiti-Rosei E
    Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Endothelial ion channels -- novel targets for antihypertensive therapy].
    Maier T; Grgic I; Busch C; Hoyer J; Köhler R
    Dtsch Med Wochenschr; 2005 Nov; 130(46):2637-9. PubMed ID: 16281159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
    [No Abstract]   [Full Text] [Related]  

  • 28. A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1,3,4-oxadiazole derivative, an L-type Ca2+ channel blocker in deoxycorticosterone acetate and N(G)-nitro-l-arginine hypertensive rats.
    Bankar GR; Nampurath GK; Nayak PG; Bhattacharya S
    Chem Biol Interact; 2010 Jan; 183(2):327-31. PubMed ID: 19912999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins: another class of antihypertensive agents?
    Milionis HJ; Liberopoulos EN; Achimastos A; Elisaf MS; Mikhailidis DP
    J Hum Hypertens; 2006 May; 20(5):320-35. PubMed ID: 16511505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological Treatment of Hypertension: Effects in Endothelial Function.
    Cobos-Segarra L; Lopez-Jaramillo P; Ponte-Negretti Ci C; Villar R; Penaherrera E
    Curr Hypertens Rev; 2018; 14(2):123-127. PubMed ID: 29737254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress of study on improvement of vascular endothelial function by Chinese herbal medicine in hypertensive patients].
    Xia CX; Lu S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Apr; 28(4):378-81. PubMed ID: 18543500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial Dysfunction and Hypertension.
    Konukoglu D; Uzun H
    Adv Exp Med Biol; 2017; 956():511-540. PubMed ID: 28035582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular effects of antihypertensive drug therapy.
    Rehman A; Schiffrin EL
    Curr Hypertens Rep; 2010 Aug; 12(4):226-32. PubMed ID: 20514556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial function and antihypertensive treatment [editoria; comment].
    Chang PC
    Cardiovasc Res; 1999 Jan; 41(1):19-20. PubMed ID: 10325949
    [No Abstract]   [Full Text] [Related]  

  • 35. The parasympathetic system and its muscarinic receptors in hypertensive disease.
    van Zwieten PA; Hendriks MG; Pfaffendorf M; Bruning TA; Chang PC
    J Hypertens; 1995 Oct; 13(10):1079-90. PubMed ID: 8586799
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition.
    Touyz RM; Lang NN; Herrmann J; van den Meiracker AH; Danser AHJ
    Hypertension; 2017 Aug; 70(2):220-226. PubMed ID: 28630211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors.
    Gibbons GH
    Curr Opin Nephrol Hypertens; 1995 Mar; 4(2):189-96. PubMed ID: 7541288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of anti-hypertensive substances].
    DE VLEESCHHOUWER GR
    Brux Med; 1960 Jan; 40():35-55. PubMed ID: 13815122
    [No Abstract]   [Full Text] [Related]  

  • 39. [Renewal in protective vascular therapy].
    Leng-Lévy J; Masquelier J
    Sem Ther; 1968 Oct; 44(8):460-1. PubMed ID: 5740246
    [No Abstract]   [Full Text] [Related]  

  • 40. Does helium act on vascular endothelial function in humans?
    Kinoshita H; Hatakeyama N; Fujiwara Y
    Anesthesiology; 2013 Aug; 119(2):488. PubMed ID: 23880992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.